GlaxoSmithKline Czech Republic invested a total of CZK 2.22 mil in 2017, down 71.6% compared to the previous year. Historically, between 2003 - 2017, the company's investments stood at a high of CZK 37.9 mil in 2005 and a low of CZK 2.22 mil in 2017.
As a percentage of total sales, investments stood at 0.077% in 2017, down from 0.230% as seen in the previous year. This is compared to an average of 0.153% over the last five years.
You can see all the company’s data at GlaxoSmithKline Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
